The blood-brain barrier: Geriatric relevance of a critical brain-body interface

Journal of the American Geriatrics Society

Volumn 58, Issue 9, 2010, Pages 1749-1757

  Zeevi, Neer ^a   Pachter, Joel ^a   McCullough, Louise D ^a   Wolfson, Leslie ^a   Kuchel, George A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

blood brain barrier; delirium; dementia; pharmacology; stroke

Indexed keywords

GELATINASE B; GLUCOSE TRANSPORTER; PROTEIN ZO1; PROTEIN ZO2;

AGING; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CELL TRANSPORT; DELIRIUM; DEMENTIA; GAIT DISORDER; HUMAN; IN VIVO STUDY; LEUKOARAIOSIS; REVIEW; SIGNAL TRANSDUCTION; URGE INCONTINENCE; AGED; BRAIN DISEASE; ENDOTHELIUM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

AGED; AGING; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN DISEASES; ENDOTHELIAL CELLS; HUMANS;

EID: 77956326640     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03011.x     Document Type: Review

References (53)

1. Wolburg H, Noell S, Mack A et al. Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 2009 335 : 75 96.
2. Farrall AJ, Wardlaw JM. Blood-brain barrier: Ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging 2009 30 : 337 352.
3. Neuwelt E, Abbott NJ, Abrey L et al. Strategies to advance translational research into brain barriers. Lancet Neurol 2008 7 : 84 96.
4. Ge S, Song L, Pachter JS. Where is the blood-brain barrier... really? J Neurosci Res 2005 79 : 421 427.
5. Persidsky Y, Ramirez SH, Haorah J et al. Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006 1 : 223 236.
6. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005 57 : 173 185.
7. Cecchelli R, Berezowski V, Lundquist S et al. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 2007 6 : 650 661.
8. Macdonald JA, Murugesan N, Pachter JS. Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. J Neurosci Res 2009 88 : 1457 1474.
9. Pelegri C, Canudas AM, del Valle J et al. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev 2007 128 : 522 528.
10. Bowman GL, Kaye JA, Moore M et al. Blood-brain barrier impairment in Alzheimer disease: Stability and functional significance. Neurology 2007 68 : 1809 1814.
11. Shah GN, Mooradian AD. Age-related changes in the blood-brain barrier. Exp Gerontol 1997 32 : 501 519.
12. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008 71 : 804 811.
13. Brown WR, Moody DM, Thore CR et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007 257 : 62 66.
14. Mooradian AD. Potential mechanisms of the age-related changes in the blood-brain barrier. Neurobiol Aging 1994 15 : 751 755 discussion 761-752, 767.
15. Choi JY, Morris JC, Hsu CY. Aging and cerebrovascular disease. Neurol Clin 1998 16 : 687 711.
16. Toornvliet R, van Berckel BN, Luurtsema G et al. Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography. Clin Pharmacol Ther 2006 79 : 540 548.
17. Bartels AL, Kortekaas R, Bart J et al. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration. Neurobiol Aging 2008 30 : 1818 1824.
18. Hof PR, Morrison JH. The aging brain: Morphomolecular senescence of cortical circuits. Trends Neurosci 2004 27 : 607 613.
19. Oztas B, Kaya M, Camurcu S. Age related changes in the effect of electroconvulsive shock on the blood brain barrier permeability in rats. Mech Ageing Dev 1990 51 : 149 155.
20. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 2008 28 : 1877 1891.
21. DiNapoli VA, Huber JD, Houser K et al. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging 2008 29 : 753 764.
22. Strbian D, Durukan A, Pitkonen M et al. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008 153 : 175 181.
23. Latour LL, Kang DW, Ezzeddine MA et al. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004 56 : 468 477.
24. Lorberboym M, Lampl Y, Sadeh M. Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke. J Nucl Med 2003 44 : 1898 1904.
25. Serena J, Blanco M, Castellanos M et al. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke 2005 36 : 1921 1926.
26. Cipolla MJ, Crete R, Vitullo L et al. Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci 2004 9 : 777 785.
27. Kharlamov A, Kharlamov E, Armstrong DM. Age-dependent increase in infarct volume following photochemically induced cerebral infarction: Putative role of astroglia. J Gerontol A Biol Sci Med Sci 2000 55A : B135 B141 discussion B142-133.
28. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 2008 28 : 9451 9462.
29. Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006 54 : 991 1001.
30. Wardlaw JM, Doubal F, Armitage P et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009 65 : 194 202.
31. Turtzo LC, McCullough LD. Sex Differences in Stroke. Cerebrovasc Dis 2008 26 : 462 474.
32. Liu F, Yuan R, Benashski SE et al. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009 29 : 792 802.
33. Wilson AC, Clemente L, Liu T et al. Reproductive hormones regulate the selective permeability of the blood-brain barrier. Biochim Biophys Acta 2008 1782 : 401 407.
34. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 : 321 333.
35. Lindgren A, Roijer A, Rudling O et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke 1994 25 : 929 934.
36. Wolfson L, Wei X, Hall CB et al. Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 2005 232 : 23 27.
37. Kuchel GA, Moscufo N, Guttmann CR et al. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2009 64A : 902 909.
38. Dufouil C, de Kersaint-Gilly A, Besancon V et al. Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort. Neurology 2001 56 : 921 926.
39. Hassan A, Hunt BJ, O'Sullivan M et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003 126 : 424 432.
40. Hanyu H, Asano T, Tanaka Y et al. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord 2002 14 : 1 6.
41. Simpson JE, Fernando MS, Clark L et al. White matter lesions in an unselected cohort of the elderly: Astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 2007 33 : 410 419.
42. van Munster BC, Korevaar JC, Korse CM et al. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry 2010 25 : 234 239.
43. Alsop DC, Fearing MA, Johnson K et al. The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci 2006 61A : 1287 1293.
44. Tinetti ME, Inouye SK, Gill TM et al. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 1995 273 : 1348 1353.
45. Inouye SK, Studenski S, Tinetti ME et al. Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007 55 : 780 791.
46. Rudolph JL, Ramlawi B, Kuchel GA et al. Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci 2008 63A : 184 189.
47. Dzenko KA, Song L, Ge S et al. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc Res 2005 70 : 53 64.
48. Ge S, Song L, Serwanski DR et al. Transcellular transport of CCL2 across brain microvascular endothelial cells. J Neurochem 2008 104 : 1219 1232.
49. ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007 14 : 488 498.
50. Kay GG, Abou-Donia MB, Messer WS Jr. et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005 53 : 2195 2201.
51. Diefenbach K, Arold G, Wollny A et al. Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged>or=50 years. BJU Int 2005 95 : 346 349.
52. Sheref SE. Pattern of CNS recovery following reversal of neuromuscular blockade. Comparison of atropine and glycopyrrolate. Br J Anaesth 1985 57 : 188 191.
53. Saija A, Princi P, Imperatore C et al. Ageing influences haloperidol-induced changes in the permeability of the blood-brain barrier in the rat. J Pharm Pharmacol 1992 44 : 450 452.